329 related articles for article (PubMed ID: 15520856)
1. Do DNA sequence variants in ABCA1 contribute to HDL cholesterol levels in the general population?
Pajukanta P
J Clin Invest; 2004 Nov; 114(9):1244-7. PubMed ID: 15520856
[TBL] [Abstract][Full Text] [Related]
2. Common and rare ABCA1 variants affecting plasma HDL cholesterol.
Wang J; Burnett JR; Near S; Young K; Zinman B; Hanley AJ; Connelly PW; Harris SB; Hegele RA
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1983-9. PubMed ID: 10938021
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population.
Frikke-Schmidt R; Nordestgaard BG; Jensen GB; Tybjaerg-Hansen A
J Clin Invest; 2004 Nov; 114(9):1343-53. PubMed ID: 15520867
[TBL] [Abstract][Full Text] [Related]
4. Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis.
Brunham LR; Singaraja RR; Hayden MR
Annu Rev Nutr; 2006; 26():105-29. PubMed ID: 16704350
[TBL] [Abstract][Full Text] [Related]
5. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
[TBL] [Abstract][Full Text] [Related]
6. The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia.
Hovingh GK; Van Wijland MJ; Brownlie A; Bisoendial RJ; Hayden MR; Kastelein JJ; Groen AK
J Lipid Res; 2003 Jun; 44(6):1251-5. PubMed ID: 12700344
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol.
Candini C; Schimmel AW; Peter J; Bochem AE; Holleboom AG; Vergeer M; Dullaart RP; Dallinga-Thie GM; Hovingh GK; Khoo KL; Fasano T; Bocchi L; Calandra S; Kuivenhoven JA; Motazacker MM
Atherosclerosis; 2010 Dec; 213(2):492-8. PubMed ID: 20880529
[TBL] [Abstract][Full Text] [Related]
8. Tangier disease caused by compound heterozygosity for ABCA1 mutations R282X and Y1532C.
Cameron J; Ranheim T; Halvorsen B; Kulseth MA; Leren TP; Berge KE
Atherosclerosis; 2010 Mar; 209(1):163-6. PubMed ID: 19765707
[TBL] [Abstract][Full Text] [Related]
9. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations.
Mott S; Yu L; Marcil M; Boucher B; Rondeau C; Genest J
Atherosclerosis; 2000 Oct; 152(2):457-68. PubMed ID: 10998475
[TBL] [Abstract][Full Text] [Related]
10. Screening for functional sequence variations and mutations in ABCA1.
Probst MC; Thumann H; Aslanidis C; Langmann T; Buechler C; Patsch W; Baralle FE; Dallinga-Thie GM; Geisel J; Keller C; Menys VC; Schmitz G
Atherosclerosis; 2004 Aug; 175(2):269-79. PubMed ID: 15262183
[TBL] [Abstract][Full Text] [Related]
11. Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants.
Quazi F; Molday RS
J Biol Chem; 2013 Nov; 288(48):34414-26. PubMed ID: 24097981
[TBL] [Abstract][Full Text] [Related]
12. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.
Clee SM; Kastelein JJ; van Dam M; Marcil M; Roomp K; Zwarts KY; Collins JA; Roelants R; Tamasawa N; Stulc T; Suda T; Ceska R; Boucher B; Rondeau C; DeSouich C; Brooks-Wilson A; Molhuizen HO; Frohlich J; Genest J; Hayden MR
J Clin Invest; 2000 Nov; 106(10):1263-70. PubMed ID: 11086027
[TBL] [Abstract][Full Text] [Related]
13. A case of Tangier disease with a novel mutation in the C-terminal region of ATP-binding cassette transporter A1.
Guan JZ; Tamasawa N; Brunham LR; Matsui J; Murakami H; Suda T; Ochiai S; Tsutsui M; Kudou K; Satoh K; Hayden MR
Am J Med Genet A; 2004 Nov; 130A(4):398-401. PubMed ID: 15384103
[TBL] [Abstract][Full Text] [Related]
14. Tangier disease: epidemiology, pathophysiology, and management.
Puntoni M; Sbrana F; Bigazzi F; Sampietro T
Am J Cardiovasc Drugs; 2012 Oct; 12(5):303-11. PubMed ID: 22913675
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1.
Oram JF
Trends Mol Med; 2002 Apr; 8(4):168-73. PubMed ID: 11927274
[TBL] [Abstract][Full Text] [Related]
16. Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia.
Slatter TL; Williams MJ; Frikke-Schmidt R; Tybjaerg-Hansen A; Morison IM; McCormick SP
Atherosclerosis; 2006 Aug; 187(2):393-400. PubMed ID: 16225879
[TBL] [Abstract][Full Text] [Related]
17. Genotypic variation in ATP-binding cassette transporter-1 (ABCA1) as contributors to the high and low high-density lipoprotein-cholesterol (HDL-C) phenotype.
Mantaring M; Rhyne J; Ho Hong S; Miller M
Transl Res; 2007 Apr; 149(4):205-10. PubMed ID: 17383594
[TBL] [Abstract][Full Text] [Related]
18. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins.
Oram JF; Vaughan AM
Curr Opin Lipidol; 2000 Jun; 11(3):253-60. PubMed ID: 10882340
[TBL] [Abstract][Full Text] [Related]
19. Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency.
Marcil M; Bissonnette R; Vincent J; Krimbou L; Genest J
Circulation; 2003 Mar; 107(10):1366-71. PubMed ID: 12642355
[TBL] [Abstract][Full Text] [Related]
20. Tangier disease and ABCA1.
Oram JF
Biochim Biophys Acta; 2000 Dec; 1529(1-3):321-30. PubMed ID: 11111099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
